La Jolla, CA, United States of America

Joan M Pierce (nee Fletcher)

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan M Pierce (nee Fletcher). Retrieved from https://idiyas.com/inventor/joan-m-pierce-nee-fletcher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joan M Pierce: Innovator in Spiroazaindole Compounds

Introduction

Joan M Pierce (nee Fletcher) is a notable inventor based in La Jolla, CA (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Joan holds 1 patent for her invention related to spiroazaindole compounds. This invention is particularly useful as HIF prolyl hydroxylase inhibitors, which can be employed in the treatment of anemia and similar conditions. Her work in this area showcases her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Joan is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. Her role at Merck has allowed her to engage in cutting-edge research and development, contributing to innovative solutions in the pharmaceutical industry.

Collaborations

Throughout her career, Joan has collaborated with esteemed colleagues, including Jeffrey John Hale and Shouwu Miao. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Joan M Pierce is a distinguished inventor whose work in spiroazaindole compounds has the potential to make a significant impact in the treatment of anemia. Her contributions to the field of medicinal chemistry reflect her dedication to innovation and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…